A 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid and methods of use thereof

Provided herein are methods for treating depression, such as major depressive disorder, in a subject in need thereof, comprising administering to the subject an effective amount of Compound 1 or a pharmaceutically acceptable salt thereof.

Saved in:
Bibliographic Details
Main Authors GUNDUZ-BRUCE, Handan, DOHERTY, James J, LASSER, Robert Alfonso, KANES, Stephen Jay, JONAS, Jeffrey M
Format Patent
LanguageEnglish
Published 16.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Provided herein are methods for treating depression, such as major depressive disorder, in a subject in need thereof, comprising administering to the subject an effective amount of Compound 1 or a pharmaceutically acceptable salt thereof.
AbstractList Provided herein are methods for treating depression, such as major depressive disorder, in a subject in need thereof, comprising administering to the subject an effective amount of Compound 1 or a pharmaceutically acceptable salt thereof.
Author DOHERTY, James J
LASSER, Robert Alfonso
GUNDUZ-BRUCE, Handan
JONAS, Jeffrey M
KANES, Stephen Jay
Author_xml – fullname: GUNDUZ-BRUCE, Handan
– fullname: DOHERTY, James J
– fullname: LASSER, Robert Alfonso
– fullname: KANES, Stephen Jay
– fullname: JONAS, Jeffrey M
BookMark eNqNyr0KwjAQAOAMOvj3DgeuBtpEhY4lKE6ddC7RXGmg5kruOtSnd_EBnL7lW6tFooQr1dRQVjpRBmcPVofI05MlyiQYwJlSN3qcs__QMA_AgpliAJ8CvFF6CgzUwcQI0mNG6rZq2fmBcfdzo_bXy93dNI7UIo_-hQmlrR-mMIWtTuZ4rkv73_oC3nE3Dw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2020395246A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2020395246A13
IEDL.DBID EVB
IngestDate Fri Nov 22 06:52:22 EST 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2020395246A13
Notes Application Number: AU20200395246
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220616&DB=EPODOC&CC=AU&NR=2020395246A1
ParticipantIDs epo_espacenet_AU2020395246A1
PublicationCentury 2000
PublicationDate 20220616
PublicationDateYYYYMMDD 2022-06-16
PublicationDate_xml – month: 06
  year: 2022
  text: 20220616
  day: 16
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies SAGE THERAPEUTICS, INC
RelatedCompanies_xml – name: SAGE THERAPEUTICS, INC
Score 3.4048066
Snippet Provided herein are methods for treating depression, such as major depressive disorder, in a subject in need thereof, comprising administering to the subject...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title A 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid and methods of use thereof
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220616&DB=EPODOC&locale=&CC=AU&NR=2020395246A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa8IwEA7ixra3zW3shxuBjT4tzCZtbB9kaKrIwCpDh2_SLAkUpBFbGe6vX1J188m3kIMjOfhyudzlOwCeVdjgxFUekrzpIy_gDYs5H4VNTIlSSUDK7g2DmPYn3vvUn1bAfPcXpuQJ_S7JEQ2ivgzei_K8Xvw_YkVlbWX-ylMzpd9641bkbKNjjI17ok7UaXVHw2jIHMZMJOnEH1bWIKGPPdo2sdKRJd6yTPvdz479l7LYdyq9c3A8Mvqy4gJUZFYDp2zXe60GTgbblLcZbtGXX4K4Dd0QZXoJGXkhSKS5Qf0m1S8gwy6K0WK9TH70fD2HlgBBpwImmYCbNtE51AqucgntnU9qdQWeet0x6yOzsNmfHWbtyf4uyDWoZjqTNwA2A9_jmGKXc-EJohJzaEgcCGWZd2iobkH9kKa7w-J7cGYta-ujXFoH1WK5kg_GExf8sTTgL4ZoikU
link.rule.ids 230,308,780,885,25564,76547
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da8IwED_Ejbm3zW3sw22BjT4tzCb9fJChreI2rTJ0-CbN0kBBWrGV4f76JVU3n3wLOTiSg9995HJ3AI_CrTOqCwNHzDax4bC6wpyJXZtYVIjQocX0hn5gdcfG28SclGC2rYUp-oR-F80RJaK-JN7zQl_P_x-x_OJvZfbMYrmVvnRGDV_bRMeESPNkaX6r0R4O_IGneZ6MJLXgQ9Hq1DWJYTVlrHRgq5m7ynn6bKm6lPmuUemcwOFQ8kvyUyhFSRUq3nb2WhWO-puUt1xu0JedQdBEuouTdIE8-kQxjzOJ-nWqnyOP6DjA89Ui_ElnqxlSDRDSmKMw4Wg9JjpDqUDLLELK54tScQ4PnfbI62J5sOmfHKbN8e4t6AWUkzSJLgHZjmkwYhGdMW5wKkKpNCLicKE671iuuILaPk7X-8n3UOmO-r1p7zV4v4FjJWX1V0q3alDOF8voVlrlnN0VwvwFLBCNNg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=A+19-nor+C3%2C3-disubstituted+C21-N-pyrazolyl+steroid+and+methods+of+use+thereof&rft.inventor=GUNDUZ-BRUCE%2C+Handan&rft.inventor=DOHERTY%2C+James+J&rft.inventor=LASSER%2C+Robert+Alfonso&rft.inventor=KANES%2C+Stephen+Jay&rft.inventor=JONAS%2C+Jeffrey+M&rft.date=2022-06-16&rft.externalDBID=A1&rft.externalDocID=AU2020395246A1